Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IB1001 in Niemann-Pick Disease Type C
NCT05163288Phase 3Recruiting
- Sponsor
- IntraBio
- Start
- Jun 2022
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of levacetylleucine in Niemann-Pick disease type C (NPC), sponsored by IntraBio. Started Jun 2022; status: recruiting.
02
Drugs
levacetylleucine
03
Conditions
Niemann-Pick disease type C (NPC)
Beyond the preview
Go deeper on NCT05163288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05163288.